microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)

  • Authors:
    • May Y.W. Wong
    • Yan Yu
    • William R. Walsh
    • Jia-Lin Yang
  • View Affiliations

  • Published online on: March 10, 2011     https://doi.org/10.3892/ijo.2011.970
  • Pages:1189-1195
0

Abstract

In the last decade, microRNAs (miRNAs; small noncoding RNA molecules) as post-transcriptional regulators have been a hotspot in research for their involvement in biological processes and tumour development. However, there have been few reviews focusing on a single miRNA family. The dysregulation of miRNAs appears to play a crucial role in cancer pathogenesis where they exert their effect as oncogenes or as tumour suppressors. This review summarises current studies on the dysregulation of the microRNA-34 (miR-34) family in different types of cancers and its role in the p53 network. The structure of the miR-34 family members includes p53-binding sites reflecting their function as tumour suppressors downstream of the p53 pathway. miR-34 dysregulation occurs in cancers, including several epithelial cancers, melanomas, neuroblastomas, leukemias and sarcomas, in the presence or absence of the p53 mutation. For these cancers, functional restoration of miR-34 is a useful novel therapy. As evidenced from preclinical and clinical studies, the miR-34 family plays an important role in the treatment of miR-34-dysregulated cancers with mutant or wild-type p53. This review will have a potential impact in the clinical treatment of p53-mutant and/or miR-34-dysregulated cancers using a miR-34 restoration approach.

Related Articles

Journal Cover

May 2011
Volume 38 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

2016 Impact Factor: 3.079
Ranked #33/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wong, M.Y., Yu, Y., Walsh, W.R., & Yang, J. (2011). microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review). International Journal of Oncology, 38, 1189-1195. https://doi.org/10.3892/ijo.2011.970
MLA
Wong, M. Y., Yu, Y., Walsh, W. R., Yang, J."microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)". International Journal of Oncology 38.5 (2011): 1189-1195.
Chicago
Wong, M. Y., Yu, Y., Walsh, W. R., Yang, J."microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)". International Journal of Oncology 38, no. 5 (2011): 1189-1195. https://doi.org/10.3892/ijo.2011.970